Transcriptional regulation of type I diabetes by NF-kappa B

J Immunol. 2003 Nov 1;171(9):4886-92. doi: 10.4049/jimmunol.171.9.4886.

Abstract

Development of type I diabetes requires coordinated expression of myriad genes responsible for the initiation and progression of the disease. Expression of these genes are regulated by a small number of transcription factors including the Rel/NF-kappaB family. To determine the roles of the Rel/NF-kappaB family in type I diabetes, we studied multiple low-dose streptozotocin-induced diabetes in mice deficient in either c-Rel or NF-kappaB1. We found that mice deficient in each of these NF-kappaB subunits were resistant to streptozotocin-induced diabetes. However, the mechanisms of the disease resistance may differ in different cases. Deficiency in c-Rel selectively reduced Th1, but not Th2 responses, whereas NF-kappaB1 deficiency had little effect on T cell responses to anti-CD3 stimulation. Death of dendritic cells was accelerated in the absence of NF-kappaB1, whereas death of macrophages and granulocytes was affected primarily by c-Rel deficiency. Furthermore, Stat-1 expression was significantly reduced in macrophages deficient in NF-kappaB1, but not c-Rel. These results indicate that both c-Rel and NF-kappaB1are essential for the development of type I diabetes and that strategies targeting each of these subunits would be effective in preventing the disease.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Apoptosis / immunology
  • DNA-Binding Proteins / biosynthesis
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism
  • Dendritic Cells / pathology
  • Diabetes Mellitus, Experimental / genetics
  • Diabetes Mellitus, Experimental / immunology
  • Diabetes Mellitus, Experimental / pathology
  • Diabetes Mellitus, Type 1 / genetics*
  • Diabetes Mellitus, Type 1 / immunology*
  • Diabetes Mellitus, Type 1 / pathology
  • Dose-Response Relationship, Immunologic
  • Immunity, Innate / genetics
  • Interferon-gamma / pharmacology
  • Lipopolysaccharides / pharmacology
  • Lymphocyte Activation / genetics
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myeloid Cells / cytology
  • Myeloid Cells / immunology
  • Myeloid Cells / metabolism
  • Myeloid Cells / pathology
  • NF-kappa B / deficiency
  • NF-kappa B / genetics
  • NF-kappa B / physiology*
  • NF-kappa B p50 Subunit
  • Proto-Oncogene Proteins c-rel / deficiency
  • Proto-Oncogene Proteins c-rel / genetics
  • Proto-Oncogene Proteins c-rel / physiology
  • STAT1 Transcription Factor
  • Signal Transduction / genetics
  • Signal Transduction / immunology
  • Streptozocin / administration & dosage
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / pathology
  • Th1 Cells / immunology
  • Th1 Cells / metabolism
  • Th1 Cells / pathology
  • Th2 Cells / immunology
  • Th2 Cells / metabolism
  • Trans-Activators / biosynthesis
  • Transcription, Genetic / immunology*

Substances

  • DNA-Binding Proteins
  • Lipopolysaccharides
  • NF-kappa B
  • NF-kappa B p50 Subunit
  • Proto-Oncogene Proteins c-rel
  • STAT1 Transcription Factor
  • Stat1 protein, mouse
  • Trans-Activators
  • Streptozocin
  • Interferon-gamma